1416 Results

People

  1. Motzer
    Motzer
  2. Vickers
    Vickers
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Saltz
    Saltz
  6. O'Reilly
    O'Reilly
  7. Mao
    Mao
  8. Morris
    Morris
  9. Seidman
    Seidman
  10. Kris
    Kris

Groups

  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)
  7. Hematologic Malignancies, Division of (169)
  8. Genitourinary Oncology Service (160)
  9. Center for Hematologic Malignancies (142)
  10. Gastrointestinal Oncology Service (126)
  1. "randomized controlled trial"
Formats
  1. Journal Article (1353)
  2. Review (19)
  3. Conference Paper (17)
  4. Editorial (9)
  5. Correspondence (5)
  6. Research Letter (5)
  7. Meeting Abstract (4)
  8. Guidelines (3)
  9. Book Section (1)
Groups
  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)

More Groups

People
  1. Robert Motzer (83)
  2. Andrew Vickers (48)
  3. Larry Norton (34)
  4. Clifford Hudis (33)
  5. Leonard Saltz (32)
  6. Eileen O'Reilly (25)

More People

Years
  1. 2025 (63)
  2. 2024 (165)
  3. 2023 (110)
  4. 2022 (81)
  5. 2021 (39)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (164)
  2. New England Journal of Medicine (65)
  3. Lancet Oncology (46)
  4. Cancer (42)
  5. Clinical Cancer Research (42)
  6. European Urology (26)

More Publications

Publishers
  1. Elsevier Inc. (187)
  2. American Society of Clinical Oncology (170)
  3. Elsevier Science, Inc. (138)
  4. Springer (79)
  5. Lippincott Williams & Wilkins (72)
  6. Wiley Blackwell (71)

More Publishers

Results (1416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A one-time pneumatic jet-injection of 5-fluorouracil and triamcinolone acetonide for treatment of hypertrophic scars—A blinded randomized controlled trial
    Journal Article

    Erlendsson, A. M.; Rosenberg, L. K.; Lerche, C. M.; Togsverd-Bo, K.; Wiegell, S. R.; Karmisholt, K.; Philipsen, P. A.; Hansen, A. C. N.; Janfelt, C.; Holmes, J.; more...
    Lasers in Surgery and Medicine (2022)

    Fulltext@MSK | Save
  • Longitudinal electronic cigarette use among patients recently diagnosed with cancer enrolled in a smoking cessation trial
    Journal Article

    Kalkhoran, S.; Streck, J. M.; Kruse, G. R.; Rigotti, N. A.; Perez, G. K.; Regan, S.; Ponzani, C. J.; Muzikansky, A.; Park, E. R.; Ostroff, J. S.
    Nicotine & Tobacco Research (2022)

    Fulltext@MSK | Save
  • Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): A randomised, phase 3 study
    Journal Article

    Motzer, R.; Porta, C.; Alekseev, B.; Rha, S. Y.; Choueiri, T. K.; Mendez-Vidal, M. J.; Hong, S. H.; Kapoor, A.; Goh, J. C.; Eto, M.; more...
    Lancet Oncology (2022)

    Fulltext@MSK | Save
  • A randomized controlled trial comparing changes in fitness with or without supervised exercise in patients initiated on enzalutamide and androgen deprivation therapy for non-metastatic castration-sensitive prostate cancer (EXTEND)
    Journal Article

    Harrison, M. R.; Davis, P. G.; Khouri, M. G.; Bartlett, D. B.; Gupta, R. T.; Armstrong, A. J.; McNamara, M. A.; Zhang, T.; Anand, M.; Onyenwoke, K.; more...
    Prostate Cancer and Prostatic Diseases (2022)

    Fulltext@MSK | Save
  • “Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)”
    Research Letter

    Rasmussen, B.; Göhring, G.; Bernard, E.; Nilsson, L.; Tobiasson, M.; Jädersten, M.; Garelius, H.; Dybedal, I.; Grønbaek, K.; Ejerblad, E.; more...
    Leukemia (2022)

    Fulltext@MSK | Save
  • Conditional survival and long-term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma
    Journal Article

    Motzer, R. J.; McDermott, D. F.; Escudier, B.; Burotto, M.; Choueiri, T. K.; Hammers, H. J.; Barthélémy, P.; Plimack, E. R.; Porta, C.; George, S.; more...
    Cancer (2022)

    Fulltext@MSK | Save
  • Amiodarone with or without N-acetylcysteine for the prevention of atrial fibrillation after thoracic surgery: A double-blind, randomized trial
    Journal Article

    Amar, D.; Zhang, H.; Chung, M. K.; Tan, K. S.; Desiderio, D.; Park, B. J.; Pedoto, A.; Roistacher, N.; Isbell, J. M.; Molena, D.; more...
    Anesthesiology (2022)

    Fulltext@MSK | Save
  • Everolimus with or without bevacizumab in advanced pNET: CALGB 80701 (Alliance)
    Journal Article

    Kulke, M. H.; Ou, F. S.; Niedzwiecki, D.; Huebner, L.; Kunz, P.; Kennecke, H. F.; Wolin, E. M.; Chan, J. A.; O'Reilly, E. M.; Meyerhardt, J. A.; more...
    Endocrine-Related Cancer (2022)

    Fulltext@MSK | Save
  • Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): Final analysis of a randomised, open-label, phase 3 study
    Journal Article

    Diaz, L. A. Jr; Shiu, K. K.; Kim, T. W.; Jensen, B. V.; Jensen, L. H.; Punt, C.; Smith, D.; Garcia-Carbonero, R.; Benavides, M.; Gibbs, P.; more...
    Lancet Oncology (2022)

    Fulltext@MSK | Save
  • SUV(fdg): A standard-uptake-value (SUV) body habitus normalizer specific to fluorodeoxyglucose (FDG) in humans
    Journal Article

    Beattie, B. J.; Akhurst, T. J.; Augensen, F.; Humm, J. L.
    PLoS ONE (2022)

    Fulltext@MSK | Save